TAYLOR ROBERT, Director, subtracted 3,294 shares of Medidata Solutions, Inc. (MDSO) from its portfolio at the rate of $90.88 per share valuing $299,359 on Jun 06. The insider left behind 41,757 shares of the company to its portfolio. Before making a move on any particular stock, readers often pay close attention to support and resistance markers. The last reported price for shares of Medidata Solutions, Inc. (MDSO) was $91.45. Currently, the 1st Resistance Point for this stock is $91.73, with a 2nd Resistance Point sitting at $92.02. Meanwhile, this company’s stock has a 1st Support Level at $91.23 and a 2nd Support Level at $91.02. Medidata Solutions, Inc. (MDSO) stock has lost -$0.56, or -0.61%, in the past five days. In the last full month, these shares have gained $3.03, or 3.43%. In the past three months, this stock’s price has risen by $16.93, or 22.72%. This year-to-date, Medidata Solutions, Inc. (MDSO) shares have gained $24.03, or 35.64%.
Analyzing price projection indicators is a helpful way to determine whether a potential stock buy is a wise choice for profits in the short term, medium term, and long term. For Medidata Solutions, Inc. (MDSO) stock, 60% of short-term indicators suggest that these shares are a “ Buy .” Meanwhile, 25% of medium-term indicators point to this stock being a “ Buy .” Looking further ahead, 67% of long-term indicators suggest that this stock is a “ Buy .”
With 62,261 K shares outstanding, this company currently has a market capitalization of $5,688,788K. Medidata Solutions, Inc. (MDSO) generates $635,700 K in annual sales, amounting to annual net income of $51,920 K. This stock has generated a 1-Year Total Return of 14.31%, a 3-Year Total Return of 103.36%, and a 5-year Total Return of 113.37%. This stock’s 5-Year Dividend Growth is 0.00%. Its Annual Dividend Yield is 0.00%, and its Annual Dividend Rate is 0.00.
In the most recently-reported fiscal quarter, which ended in Mar-19, Medidata Solutions, Inc. (MDSO) reported earnings of $0.45 per share. Wall Street analysts, on average, were expecting the company to report earnings of $0.35 per share, representing a 0.1 difference and 28.28% surprise. In the previous quarter ending in Dec-18, the reported earnings of $0.45 represented a 0.08 difference from the consensus estimate calling for $0.37 per share, which was a 20.45% surprise.
For the current fiscal quarter, which is set to end in 06/2019, the average earnings estimate is $0.17 per share. This estimate came from a total of 4 Wall Street Analysts. Of those market experts, the high estimate was $0.19 and the low estimate was $0.15. In the year-ago quarter, Medidata Solutions, Inc. (MDSO) generated per-share earnings of $0.24. If the analysts are correct about the current quarter’s earnings, the growth will be -29.17% .
Turning our focus now to insider trading activity, there have been 7 purchases (28,950 shares in total) and 3 sale (8,739 shares in total) in the last 3 months. In the last 6 months, there have been 23 insider buys amounting to 601,622 shares and 36 insider sales amounting to 330,245 shares. In the past full year, 27 insider purchases were made (involving 645,904 shares) and 50 insider sell-offs equivalent to 420,696 shares.
Moving onto liquidity, Medidata Solutions, Inc. (MDSO) has a Current Ratio of 2.71, a Quick Ratio of 2.71 and a Cash Ratio of 1.41. Looking at this company’s capital structure, its Total Debt to Total Equity is 13.99, its Total Debt to Total Capital is 12.28, and its Total Debt to Total Assets is now 9.68. Looking even further ahead into the future, its Long-Term Debt to Equity is 13.99 and its Long-Term Debt to Total Capital is 12.28.